Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Zoolog Sci ; 41(3): 263-274, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38809865

RESUMEN

cytochrome P-450, 21-hydroxylase (cyp21a2), encodes an enzyme required for cortisol biosynthesis, and its mutations are the major genetic cause of congenital adrenal hyperplasia (CAH) in humans. Here, we have generated a null allele for the medaka cyp21a2 with a nine base-pair insertion which led to a truncated protein. We have observed a delay in hatching and a low survival rate in homozygous mutants. The interrenal gland (adrenal counterpart in teleosts) exhibits hyperplasia and the number of pomca-expressing cells in the pituitary increases in the homozygous mutant. A mass spectrometry-based analysis of whole larvae confirmed a lack of cortisol biosynthesis, while its corresponding precursors were significantly increased, indicating a systemic glucocorticoid deficiency in our mutant model. Furthermore, these phenotypes at the larval stage are rescued by cortisol. In addition, females showed complete sterility with accumulated follicles in the ovary while male homozygous mutants were fully fertile in the adult mutants. These results demonstrate that the mutant medaka recapitulates several aspects of cyp21a2-deficiency observed in humans, making it a valuable model for studying steroidogenesis in CAH.


Asunto(s)
Oryzias , Esteroide 21-Hidroxilasa , Animales , Oryzias/genética , Esteroide 21-Hidroxilasa/genética , Esteroide 21-Hidroxilasa/metabolismo , Femenino , Masculino , Glucocorticoides/metabolismo , Hiperplasia/genética , Hiperplasia/veterinaria , Hidrocortisona/metabolismo , Hiperplasia Suprarrenal Congénita/genética , Hiperplasia Suprarrenal Congénita/veterinaria , Mutación , Enfermedades de los Peces/genética , Larva/genética , Larva/metabolismo
3.
Res Vet Sci ; 93(1): 97-9, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21612807

RESUMEN

Hypoglycaemia is frequently identified in canine cases of hypoadrenocorticism. Potassium and glucose cellular uptake are intimately linked by insulin. We hypothesized that in canine hypoadrenocorticism, hyperkalaemia would stimulate insulin release as a protective mechanism, translocating potassium from the extracellular compartment to the intracellular compartment and also lower glucose concentrations. Serum insulin concentrations were measured in 11 consecutive cases of canine hypoadrenocorticism which were hyperkalaemic and 33 dogs with non-adrenal illness. There was no significant difference between insulin concentrations in the two populations, and no correlation between insulin and potassium concentration in the hypoadrenal group. Thus, no support for the hypothesis was found, although multiple other factors such as pH and osmolality may be obscuring an effect.


Asunto(s)
Hiperplasia Suprarrenal Congénita/veterinaria , Enfermedades de los Perros/sangre , Insulina/sangre , Hiperplasia Suprarrenal Congénita/sangre , Hiperplasia Suprarrenal Congénita/fisiopatología , Animales , Enfermedades de los Perros/fisiopatología , Perros , Femenino , Hiperpotasemia/sangre , Hiperpotasemia/fisiopatología , Hiperpotasemia/veterinaria , Masculino
4.
J Am Vet Med Assoc ; 225(2): 238-41, 231, 2004 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-15323380

RESUMEN

A calico-colored domestic shorthair cat was examined because of possible cryptorchidism. The cat had a fully formed penis, prepuce, and scrotum, but no descended testes, and exploratory laparotomy revealed a grossly normal female internal genital tract (ie, 2 ovaries, 2 uterine horns, and uterine body). Chromosomal analysis revealed a normal female (38,XX) karyotype. Four months later, the cat was examined because of polyuria, polydipsia, and inappropriate urination. Serum cortisol and aldosterone concentrations were low, and results of an ACTH stimulation test were suggestive of decreased adrenal gland function. Serum ACTH, testosterone, androstenedione, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, and deoxycorticosterone concentrations were high, and a diagnosis of congenital adrenal hyperplasia secondary to 11beta-hydroxylase deficiency was made. Treatment with prednisone diminished clinical signs but had a variable effect on corticosteroids hormone concentrations. To the author's knowledge, this is the first report of congenital adrenal hyperplasia in a cat.


Asunto(s)
Hiperplasia Suprarrenal Congénita/veterinaria , Enfermedades de los Gatos/diagnóstico , Glándulas Suprarrenales/diagnóstico por imagen , Hiperplasia Suprarrenal Congénita/diagnóstico , Hiperplasia Suprarrenal Congénita/genética , Animales , Enfermedades de los Gatos/congénito , Enfermedades de los Gatos/genética , Gatos , Diagnóstico Diferencial , Trastornos del Desarrollo Sexual/diagnóstico , Trastornos del Desarrollo Sexual/veterinaria , Femenino , Cariotipificación/veterinaria , Masculino , Esteroide 11-beta-Hidroxilasa/genética , Esteroide 11-beta-Hidroxilasa/metabolismo , Ultrasonografía
5.
Res Vet Sci ; 73(2): 159-63, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12204635

RESUMEN

A Strong breed predisposition to canine congenital adrenal hyperplasia-like syndrome (CAH-LS) exists and implies there is an hereditary cause. Pomeranians, one of the most predisposed breeds, have been reported to have partial adrenal dysfunction that could be associated with the pathogenesis of CAH-LS. In this study, the full-length complementary DNA (cDNA) of canine 21-OH, whose mutations are most likely responsible for the adrenal dysfunction in Pomeranians, was initially obtained from adrenal gland RNA by reverse transcription-polymerase chain reaction (RT-PCR), and its nucleotide sequence was determined. Genomic DNA samples from 16 Pomeranians and 30 control dogs, of seven different breeds, were tested for 21-OH gene polymorphisms by direct sequencing. No mutations affecting the primary structure and the transcriptional level of the 21-OH enzyme were found in Pomeranians. Our results indicate that the adrenal dysfunction in Pomeranians is not due to mutations of the 21-OH gene. This contrasts with the human form of CAH where 21-OH gene mutations are the major cause of the disease.


Asunto(s)
Hiperplasia Suprarrenal Congénita/genética , Hiperplasia Suprarrenal Congénita/veterinaria , Enfermedades de los Perros/enzimología , Enfermedades de los Perros/genética , Perros/genética , Polimorfismo Genético/genética , Esteroide 21-Hidroxilasa/genética , Región de Flanqueo 5'/genética , Hiperplasia Suprarrenal Congénita/enzimología , Animales , Clonación Molecular , Perros/clasificación , Femenino , Frecuencia de los Genes , Masculino , Síndrome
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA